The first two versions of Google's software (to predict protein folding) were , including the one that earned its developers the 2024 Nobel Prize in Chemistry. There were no restrictions on commercial use. But the third and most recent version blocks free commercial use, and is poised to earn $100+ billion from partnerships with companies. Then three MIT students reverse-engineered AlphaFold 3 and released their OSS model, called , with no restrictions on commercial reuse. Like Red Hat, the Boltz team is making good money selling services while leaving the software free and open.
implicator.ai/when-google-lock

0
0
0

If you have a fediverse account, you can quote this note from your own instance. Search https://fediscience.org/users/petersuber/statuses/115877230113067786 on your instance and quote it. (Note that quoting is not supported in Mastodon.)